FdaApplication
BLA 761079
Identifiers
- fda_app_no: BLA761079
Properties
| Property | Value |
|---|---|
| applicant_name | BioMarin Pharmaceutical Inc. |
| application_type | BLA |
| approval_date | 2018-05-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PALYNZIQ | PEGVALIASE-PQPZ | 10MG/0.5ML | Injection |
| PALYNZIQ | PEGVALIASE-PQPZ | 2.5MG/0.5ML | Injection |
| PALYNZIQ | PEGVALIASE-PQPZ | 20MG/ML | Injection |
3 products